Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Exercise/Conversion of 2,500 SUPN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 2,500 | n/a |
| Jul 31, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 2,500 | n/a |
| Mar 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 22,750 | $836.1K |
| Feb 26, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,250 | n/a |
| Feb 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,125 | n/a |
| Feb 20, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 13,500 | n/a |
| Dec 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 1,500 | n/a |
| Nov 17, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,500 | n/a |
| Aug 27, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 1,250 | n/a |
| Aug 8, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,250 | n/a |